Advanced Drug Delivery Systems (ADDS) France
Research
Date range: 1 December 2020 - 30 November 2021
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Advanced Drug Delivery Systems (ADDS) published between 1 December 2020 - 30 November 2021 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
1 | 0.05 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 1 | 0.05 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Compare Advanced Drug Delivery Systems (ADDS) with other institutions
Collaboration
Date range: 1 December 2020 - 30 November 2021
International vs. domestic collaboration by Share
- 65.69% Domestic
- 34.31% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Advanced Drug Delivery Systems (ADDS) by Share (7 total)
-
Advanced Drug Delivery Systems (ADDS) and Jean Pierre Aubert Research Centre (JPARC)
(0.59)
-
Advanced Drug Delivery Systems (ADDS) and National Institute for Health and Medical Research (INSERM)
(0.21)
-
Advanced Drug Delivery Systems (ADDS) and Centre Hospitalier Universitaire de Lille (CHU Lille)
(0.20)
-
Advanced Drug Delivery Systems (ADDS) and University of Lille Nord de France
(0.20)
-
Advanced Drug Delivery Systems (ADDS) and Institut de Recherches sur le Cancer de Lille (IRCL)
(0.18)
-
Advanced Drug Delivery Systems (ADDS) and University of Bordeaux
(0.08)
-
Advanced Drug Delivery Systems (ADDS) and Magendie Neurocenter - Pathophysiology of Neural Plasticity
(0.07)
Top 10 international collaborators with Advanced Drug Delivery Systems (ADDS) by Share (9 total)
-
Advanced Drug Delivery Systems (ADDS) and University of Lausanne (UNIL)
(0.18)
-
Advanced Drug Delivery Systems (ADDS) and University of Liège (ULg)
(0.14)
-
Advanced Drug Delivery Systems (ADDS) and Oregon Health and Science University (OHSU)
(0.09)
-
Advanced Drug Delivery Systems (ADDS) and University of Michigan (U-M)
(0.09)
-
Advanced Drug Delivery Systems (ADDS) and University of Cordoba (UCO)
(0.07)
-
Advanced Drug Delivery Systems (ADDS) and Institute of Health Carlos III (ISCIII)
(0.06)
-
Advanced Drug Delivery Systems (ADDS) and Instituto Maimonides de Investigaciones Biomédicas de Córdoba (IMIBIC)
(0.06)
-
Advanced Drug Delivery Systems (ADDS) and Hospital Universitario Reina Sofía
(0.05)
-
Advanced Drug Delivery Systems (ADDS) and Reina Sofia Foundation
(0.05)
Relationships
Partner Institutions
Advanced Drug Delivery Systems (ADDS) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.